|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polyak K: Heterogeneity in breast cancer.
J Clin Invest. 121:3786–3788. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qin XJ and Ling BX: Proteomic studies in
breast cancer (Review). Oncol Lett. 3:735–743. 2012.PubMed/NCBI
|
|
4
|
Sun B, Zhang S, Zhang D, Li Y, Zhao X, Luo
Y and Guo Y: Identification of metastasis-related proteins and
their clinical relevance to triple-negative human breast cancer.
Clin Cancer Res. 14:7050–7059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Teng YH, Tan WJ, Thike AA, Cheok PY, Tse
GM, Wong NS, Yip GW, Bay BH and Tan PH: Mutations in the epidermal
growth factor receptor (EGFR) gene in triple negative breast
cancer: Possible implications for targeted therapy. Breast Cancer
Res. 13:R352011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueno NT and Zhang D: Targeting EGFR in
triple negative breast cancer. J Cancer. 2:324–328. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu M, Mo QG, Wei CY, Qin QH, Huang Z and
He J: Platinum- based chemotherapy in triple-negative breast
cancer: A meta-analysis. Oncol Lett. 5:983–991. 2013.PubMed/NCBI
|
|
8
|
Yewale C, Baradia D, Vhora I, Patil S and
Misra A: Epidermal growth factor receptor targeting in cancer: A
review of trends and strategies. Biomaterials. 34:8690–8707. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59(Suppl 2):
21–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomas A, Futter CE and Eden ER: EGF
receptor trafficking: Consequences for signaling and cancer. Trends
Cell Biol. 24:26–34. 2014. View Article : Google Scholar :
|
|
11
|
Masuda H, Zhang D, Bartholomeusz C,
Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth
factor receptor in breast cancer. Breast Cancer Res Treat.
136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhargava R, Gerald WL, Li AR, Pan Q, Lal
P, Ladanyi M and Chen B: EGFR gene amplification in breast cancer:
Correlation with epidermal growth factor receptor mRNA and protein
expression and HER-2 status and absence of EGFR-activating
mutations. Mod Pathol. 18:1027–1033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masuda H, Zhang D, Bartholomeusz C,
Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth
factor receptor in breast cancer. Breast Cancer Res Treat.
136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gluz O, Liedtke C, Gottschalk N, Pusztai
L, Nitz U and Harbeck N: Triple-negative breast cancer - current
status and future directions. Ann Oncol. 20:1913–1927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corkery B, Crown J, Clynes M and O'Donovan
N: Epidermal growth factor receptor as a potential therapeutic
target in triple-negative breast cancer. Ann Oncol. 20:862–867.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Ding W, Mirza A, Van Arsdale T, Wei
I, Bishop WR, Basso A, McClanahan T, Luo L, Kirschmeier P, et al:
Integrative genomics revealed RAI3 is a cell growth-promoting gene
and a novel P53 transcriptional target. J Biol Chem.
280:12935–12943. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao Q, Fujimoto J, Men T, Ye X, Deng J,
Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, et al:
Identification of the retinoic acid-inducible Gprc5a as a new lung
tumor suppressor gene. J Natl Cancer Inst. 99:1668–1682. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kadara H, Fujimoto J, Men T, Ye X, Lotan
D, Lee JS and Lotan R: A Gprc5a tumor suppressor loss of expression
signature is conserved, prevalent, and associated with survival in
human lung adenocarcinomas. Neoplasia. 12:499–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin X, Zhong S, Ye X, Liao Y, Yao F, Yang
X, Sun B, Zhang J, Li Q, Gao Y, et al: EGFR phosphorylates and
inhibits lung tumor suppressor GPRC5A in lung cancer. Mol Cancer.
13:2332014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong S, Yin H, Liao Y, Yao F, Li Q, Zhang
J, Jiao H, Zhao Y, Xu D, Liu S, et al: Lung tumor suppressor GPRC5A
binds EGFR and restrains its effector signaling. Cancer Res.
75:1801–1814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sokolenko AP, Bulanova DR, Iyevleva AG,
Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ES,
Mitiushkina NV, Suspitsin EN, Yanus GA, et al: High prevalence of
GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Int J Cancer. 134:2352–2358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma T, Yang L and Zhang J: MiRNA-542–3p
downregulation promotes trastuzumab resistance in breast cancer
cells via AKT activation. Oncol Rep. 33:1215–1220. 2015.PubMed/NCBI
|
|
23
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng Y and Lotan R: Molecular cloning and
characterization of a novel retinoic acid-inducible gene that
encodes a putative G protein-coupled receptor. J Biol Chem.
273:35008–35015. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tao Q, Cheng Y, Clifford J and Lotan R:
Characterization of the murine orphan G-protein-coupled receptor
gene Rai3 and its regulation by retinoic acid. Genomics.
83:270–280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mayer IA, Abramson VG, Lehmann BD and
Pietenpol JA: New strategies for triple-negative breast
cancer--deciphering the heterogeneity. Clin Cancer Res. 20:782–790.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taurin S, Allen KM, Scandlyn MJ and
Rosengren RJ: Raloxifene reduces triple-negative breast cancer
tumor growth and decreases EGFR expression. Int J Oncol.
43:785–792. 2013.PubMed/NCBI
|
